We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2010 by St George's Healthcare NHS Trust.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01154998
First Posted: July 1, 2010
Last Update Posted: July 1, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
St George's Healthcare NHS Trust
  Purpose
There is a rare condition causing scarring of the lungs termed interstitial lung disease. This comprises a group of conditions which can be divided into separate diseases. The aim of this study is compare a group of patients (the cases) with 2 types of this disease (fibrotic non-specific interstitial pneumonia (NSIP) and idiopathic pulmonary fibrosis (IPF)) with patients without the disease. The study will look at the 2 groups and their exposures to factors such as medications, smoking, previous jobs, previous medical problems and specifically heart disease and any operations or procedures involving the heart. There have been previous studies showing a link between heart disease and scarring of the lungs. This study will look at whether this association is stronger in one or the other type of lung scarring diseases.

Condition
Idiopathic Pulmonary Fibrosis Interstitial Pneumonia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Case-Control Study of Fibrotic Interstitial Lung Disease and it's Association With Cardiac Disease or Cardiac Intervention.

Resource links provided by NLM:


Further study details as provided by St George's Healthcare NHS Trust:

Estimated Enrollment: 360
Study Start Date: July 2010
Estimated Study Completion Date: April 2011
Estimated Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts
Cases
Controls

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cases - patients with IPF or UIP. Controls - hospital clinic attenders.
Criteria

Inclusion Criteria:

  • idiopathic fibrotic lung disease

Exclusion Criteria:

  • non idiopathic fibrotic lung disease
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154998


Contacts
Contact: Felix Chua, MBBS 0208 725 1261 felix.chua@stgeorges.nhs.uk

Locations
United Kingdom
St George's Hospital Not yet recruiting
London, United Kingdom, SW17 0QT
Sponsors and Collaborators
St George's Healthcare NHS Trust
  More Information

Responsible Party: Dr Felix Chua, St George's Healthcare NHS Trust
ClinicalTrials.gov Identifier: NCT01154998     History of Changes
Other Study ID Numbers: 10/H1102/46
First Submitted: June 30, 2010
First Posted: July 1, 2010
Last Update Posted: July 1, 2010
Last Verified: June 2010

Keywords provided by St George's Healthcare NHS Trust:
non-specific interstitial pneumonia

Additional relevant MeSH terms:
Pneumonia
Lung Diseases
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial
Heart Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Cardiovascular Diseases